Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study
Crossref DOI link: https://doi.org/10.1007/s40801-016-0093-2
Published Online: 2016-10-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gu, Tao
Shah, Neel
Deshpande, Gaurav
Tang, Derek H.
Eisenberg, Debra F.
Funding for this research was provided by:
Immunex Corporation, a wholly owned subsidiary of Amgen Inc.
License valid from 2016-10-18